Zerr I - Search Results

1

The importance of ongoing international surveillance for Creutzfeldt-Jakob disease.

Watson N, Brandel JP, Green A, Hermann P, Ladogana A, Lindsay T, Mackenzie J, Pocchiari M, Smith C, Zerr I, Pal S. Watson N, et al. Among authors: zerr i. Nat Rev Neurol. 2021 Jun;17(6):362-379. doi: 10.1038/s41582-021-00488-7. Epub 2021 May 10. Nat Rev Neurol. 2021. PMID: 33972773 Free PMC article. Review.

2

Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease.

Steinhoff BJ, Räcker S, Herrendorf G, Poser S, Grosche S, Zerr I, Kretzschmar H, Weber T. Steinhoff BJ, et al. Among authors: zerr i. Arch Neurol. 1996 Feb;53(2):162-6. doi: 10.1001/archneur.1996.00550020074017. Arch Neurol. 1996. PMID: 8639066 Clinical Trial.

3

Apolipoprotein E phenotype frequency and cerebrospinal fluid concentration are not associated with Creutzfeldt-Jakob disease.

Zerr I, Helmhold M, Poser S, Armstrong VW, Weber T. Zerr I, et al. Arch Neurol. 1996 Dec;53(12):1233-8. doi: 10.1001/archneur.1996.00550120041014. Arch Neurol. 1996. PMID: 8970451

4

Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

Otto M, Wiltfang J, Tumani H, Zerr I, Lantsch M, Kornhuber J, Weber T, Kretzschmar HA, Poser S. Otto M, et al. Among authors: zerr i. Neurosci Lett. 1997 Apr 11;225(3):210-2. doi: 10.1016/s0304-3940(97)00215-2. Neurosci Lett. 1997. PMID: 9147407

5

S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

Otto M, Stein H, Szudra A, Zerr I, Bodemer M, Gefeller O, Poser S, Kretzschmar HA, Mäder M, Weber T. Otto M, et al. Among authors: zerr i. J Neurol. 1997 Sep;244(9):566-70. doi: 10.1007/s004150050145. J Neurol. 1997. PMID: 9352454

6

Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease.

Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T. Zerr I, et al. Ann Neurol. 1998 Jan;43(1):32-40. doi: 10.1002/ana.410430109. Ann Neurol. 1998. PMID: 9450766

7

Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJD.

Will RG, Alperovitch A, Poser S, Pocchiari M, Hofman A, Mitrova E, de Silva R, D'Alessandro M, Delasnerie-Laupretre N, Zerr I, van Duijn C. Will RG, et al. Among authors: zerr i. Ann Neurol. 1998 Jun;43(6):763-7. doi: 10.1002/ana.410430611. Ann Neurol. 1998. PMID: 9629846

8

Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD).

van Duijn CM, Delasnerie-Lauprêtre N, Masullo C, Zerr I, de Silva R, Wientjens DP, Brandel JP, Weber T, Bonavita V, Zeidler M, Alpérovitch A, Poser S, Granieri E, Hofman A, Will RG. van Duijn CM, et al. Among authors: zerr i. Lancet. 1998 Apr 11;351(9109):1081-5. doi: 10.1016/s0140-6736(97)09468-3. Lancet. 1998. PMID: 9660576

9

Phenotypic variability in fatal familial insomnia (D178N-129M) genotype.

Zerr I, Giese A, Windl O, Kropp S, Schulz-Schaeffer W, Riedemann C, Skworc K, Bodemer M, Kretzschmar HA, Poser S. Zerr I, et al. Neurology. 1998 Nov;51(5):1398-405. doi: 10.1212/wnl.51.5.1398. Neurology. 1998. PMID: 9818868

10

The Heidenhain variant of Creutzfeldt-Jakob disease.

Kropp S, Schulz-Schaeffer WJ, Finkenstaedt M, Riedemann C, Windl O, Steinhoff BJ, Zerr I, Kretzschmar HA, Poser S. Kropp S, et al. Among authors: zerr i. Arch Neurol. 1999 Jan;56(1):55-61. doi: 10.1001/archneur.56.1.55. Arch Neurol. 1999. PMID: 9923761

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

408 results

Search Page